Barnesiella intestinihominis is a species of bacteria that is part of the human gut microbiota. This species is categorized within the family Porphyromonadaceae. It has garnered interest within the scientific and medical communities due to its potential role in human health and disease. Research has suggested that Barnesiella intestinihominis may influence the immune system, contribute to maintaining gut barrier integrity, and affect the body’s defense against pathogenic infections. Furthermore, its presence or abundance in the gut microbiome has been explored for potential associations with responses to specific treatments, such as the efficacy of chemotherapy and immunotherapy in cancer patients. Despite its promise, the mechanisms through which Barnesiella intestinihominis exerts its effects remain under investigation, highlighting the need for further research to elucidate its functions and therapeutic potential.